Polly,
I'm sorry, I realize that I shouldn't be sounding so cynical, because Dr. Fasano's work really is groundbreaking, and his contribitions to the knowledge base are unquestionably virtually priceless, for furthering our understanding of gluten-sensitivity, (and other food sensitivities, as well, obviously). As you probably recall, early on, I was really enthusiastic about this line of research.
As best I can determine, the recent announcement of the discovery of the "three major peptides" that cause celiac-type reactions, is the primary source of the wet blanket that dampened my enthusiasm. I realize that this announcement has nothing to do with Dr. Fasano's project, but the attitude of the researchers seemed to change the entire atmosphere surrounding the search for a "solution" to the gluten-sensitivity problem, (or at least, it changed my perception of it). Those guys detected close to a hundred peptides that are implicated in celiac-type reactions, then they narrowed that down to only 3 that are "the worst offenders". They are already working on a treatment program to "desensitize" the immune system toward those 3 peptides, with the obvious intention of marketing it and getting rich. Well duh! What about all those other gluten, (both gliadin and glutenin), peptides that we react to. And what about all those that still remain undetected/unidentified? The immune system is not going to ignore them, simply because it has been "desensitized" to certain other peptides. I guess I'm just turned off by "research scientists" who are so quick to try to rush something, (anything), to market, in the hopes of wealth and prestige, (when any fool can see that their program falls far short of a workable plan). And yet, people will blindly rush to pay for this stuff, because they are so desperate for an "easy" solution.
Yes, that has nothing to do with Dr. Fasano's work, but it really illustrates the mercenary attitude of research scientists these days. In a word, to me it appears to be just plain greedy. What has happened to the days when researchers pursued their work simply for the joy of "discovery"? At one time, researchers "burned to learn". These days, they apparently burn to get rich. No, I don't begrudge them the spoils of their work, but clearly, many of them are trying to rush a "half-baked" product to market, before someone else beats them to it.
I hope that Dr. Fasano, (ALBA Therapeutics), gets there first, because his technology does appear to have a good chance of working effectively, (and hopefully, safely). If someone else gets a product on the market first, though, the odds are very high that it may suppress the clinical symptoms below the threshold for a reaction, while allowing "hidden" damage to acrue to the intestines. To most people, only symptoms matter - they really don't care what might be happening to their internal organs, (they do care, deep down, but they simply shut it out, by ignoring it). That's a form of denial, of course, and it's the default reaction.
Even with ALBA's product, there is no telling what will turn up, years from now, as millions of people drop their diet, and rely on the pill. These are uncharted waters, and we all know how poorly the medical system monitors the effects of such treatments. For many decades, it was assumed that the GF diet promptly restores normal histology to the small intestine. Only in the last few years has research gotten around to proving the fallacy of that claim - it actually takes years for histology to normalize. Anyone who takes pills to treat a medical issue is a "guinea pig", and they remain a guinea pig for the rest of their lives, even if they stop taking the drug. We know that diet is a safe way to treat food sensitivities. We absolutely do not know if any pill is safe to treat food sensitivities - not in the long run.
That said, there's no question in my mind that Dr. Fasano's product has the best prospects of anything else that I've seen proposed, for anyone interested in treating food sensitivities with a pill.
Love,
Tex